US Patent 8106209 Substituted aminothiazole prodrugs of compounds with anti-HCV activity
Patent 8106209 was granted and assigned to Achillion Pharmaceuticals on January, 2012 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
June 5, 2009
Date of Patent
January 31, 2012
Patent Application Number
12479213
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 8106209 Substituted aminothiazole prodrugs of compounds with anti-HCV activity
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
